AAPS Foundation to Promote Drug Development - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAPS Foundation to Promote Drug Development



Untitled Document

AAPS announced the launch of the AAPS Foundation, an information network for pharmaceutical scientists around the world. The foundation will help advance the contributions of the pharmaceutical sciences to global health.

The AAPS Foundation will support scientists and initiatives that promote the discovery, development, and manufacture of drugs by attracting and providing resources used to advance research, education, and training. The foundation hopes to assist current pharmaceutical scientists, in addition to expanding and engaging the interests of future generations of scientists.

AAPS Foundation funding priorities will include graduate student fellowships, through AAPS’ strategic partnership with the American Foundation for Pharmaceutical Educations, leaders with a 70-year history in graduate education; Undergraduate Research Grants, in outstanding academic laboratories, to encourage those investigating a research career; multiyear new investigator grants to the most promising young faculty members; a Leadership Institute to ensure that current students and research professionals will thrive in the pharmaceutical industry, academia, or government; and a Teach the Teacher program, developed to increase outreach to K-12 students and also establish ongoing relationships with high school science and math teachers around the country and globe.

Source: AAPS

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
20%
Attracting a skilled workforce
28%
Obtaining/maintaining adequate financing
12%
Regulatory compliance
40%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here